These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35017593)

  • 1. Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia.
    Al-Mekhlafi HM; Madkhali AM; Abdulhaq AA; Atroosh WM; Ghzwani AH; Zain KA; Ghailan KY; Hamali HA; Mobarki AA; Alharazi TH; Eisa ZM; Lau YL
    Sci Rep; 2022 Jan; 12(1):517. PubMed ID: 35017593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The return of chloroquine-sensitive Plasmodium falciparum parasites in Jazan region, southwestern Saudi Arabia over a decade after the adoption of artemisinin-based combination therapy: analysis of genetic mutations in the pfcrt gene.
    Madkhali AM; Abdulhaq AA; Atroosh WM; Ghzwani AH; Zain KA; Ghailan KY; Hamali HA; Mobarki AA; Eisa ZM; Lau YL; Al-Mekhlafi HM
    Parasitol Res; 2021 Nov; 120(11):3771-3781. PubMed ID: 34561749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4years after implementation of artemisinin combination therapy in Iran.
    Pirahmadi S; Zakeri S; Afsharpad M; Djadid ND
    Infect Genet Evol; 2013 Mar; 14():327-34. PubMed ID: 23287027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
    Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
    Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
    PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
    Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
    Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
    Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33262257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
    She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
    BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evidence for
    Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
    Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
    Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
    Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.
    Lobo E; de Sousa B; Rosa S; Figueiredo P; Lobo L; Pateira S; Fernandes N; Nogueira F
    Malar J; 2014 Aug; 13():300. PubMed ID: 25098280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
    Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
    Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
    Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
    Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.